ロード中...
Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
ErbB2 is an important member of the ErbB family, which activates growth and proliferation signaling pathways. ErbB2 is often overexpressed in various malignancies, especially in breast cancer, and is a common target for anti-cancer drugs. Breast cancer is currently one of the leading mortality cause...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5323158/ https://ncbi.nlm.nih.gov/pubmed/27542246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11323 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|